Julian Schubert - Profile and Investment Details

Investor Profile

Julian Schubert is a Venture Capital, Corporate Venture Capital based in Baden-Württemberg, Germany with a diverse investment portfolio that includes companies such as FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq, Asceneuron, DNA Script, Peratech, Medisafe, Padlock Therapeutics, ARTSaVIT, Macrophage Pharma, Tipe, F-star Biotechnology, iOnctura, Synaffix BV, Akili Interactive Labs, Calypso Biotech, Translate Bio, SeeQC, FanAI, Ribometrix, Artios Pharma, Storm Therapeutics, Metalenz, SynSense, Forendo Pharma, Bird Rock Bio, Metabomed, NanoSyrinx, Xilio Therapeutics, Alcan Systems, Rewind Therapeutics, Canbex Therapeutics, curbFlow, Raze Therapeutics, Neurable, ApoGen Biotechnologies, Ambrx, aveni, Scipio Bioscience, Mighty Bear Games, Galecto, Progyny, Mosa Meat, Altoida, Anaphore, Inthera Bioscience, Wiliot, Gamelynx, IOmx Therapeutics, ObsEva, Prexton Therapeutics, . Over time, Julian Schubert has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Julian Schubert is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Research and Development, Drug Discovery, Wellness, Corporate Social Responsibility Management, Consumer Goods, Infrastructure, Chemical, Life Science, Science, Information Technology (IT), 3D Technology, Mobile, Technology, Tech hardware, Manufacturing, Biotechnology, Semiconductor Manufacturing Equipment, Medical Devices, Food and Beverage, Neuroscience, Digital Transformation, Consumer Internet, Research, Hardware, Digital Health, Medical, Sensors, Information Technology, B2B, Therapeutics, Advanced Materials, Quantum Computing, Material Science, Black / African American Founded, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Julian Schubert, as their portfolio suggests a familiarity and interest in this area.

Understanding Julian Schubert’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.